Part 1: Understanding Substance Use Disorders.- Section 1. Introduction of Substance Use Disorders.- Chapter 1 Definition and Classification.- Chapter 2 Epidemiology and Global Impact.- Chapter 3 Historical Perspectives.- Section 2. Neurobiology of Addiction.
- Chapter 4 Brain Structures and Functions.- Chapter 5 Neurotransmitters and Neural Pathways.- Chapter 6 Genetics and Addiction.- Section 3. Psychosocial Factors in Substance Use.- Chapter 7 Social Determinants.- Chapter 8 Psychological Factors.- Chapter 9 Cultural Influences.
- Chapter 10 Stigma of Addiction.- Chapter 11 Substance use in Special Populations.- Section 4. Developmental Aspects of Substance Use.- Chapter 12 Adolescence and Substance Use.- Chapter 13 Adult Onset and Aging.- Part 2: Assessment and Diagnosis.- Section 5.
Screening and Assessment Tools.- Chapter 14 Standardized Questionnaires.- Chapter 15 Diagnostic Interviews.- Chapter 16 Laboratory Workup.- Chapter 17 Biological Markers.- Section 6. Diagnostic Criteria for Substance Use Disorders.- Chapter 18 DSM-5 Criteria.
- Chapter 19 ASAM Criteria.- Chapter 19 Critiques and Controversies.- Section 7. Substance Use Disorders.- Chapter 20 Opioid Use Disorder.- Chapter 21 Alcohol Use Disorder.- Chapter 22 Addiction to Nonalcohol Sedative-Hypnotics and Anxiolytics.- Chapter 23 Nicotine and Tobacco Use Disorders.
- Chapter 23 Stimulant Use Disorder.- Chapter 24 Addiction to Caffeine.- Chapter 25 Cannabis Use Disorder.- Chapter 26 Hallucinogen Use Disorder.- Chapter 27 Addiction to Dissociative Substances.- Chapter 28 Addiction to Inhalants.- Chapter 29 Addiction to Anabolic-Androgenic Steroids.- Section 8.
Behavioral Addictions.- Chapter 30 Gambling Addiction.- Chapter 31 Internet and Technology Addiction.- Chapter 32 Gaming Addiction.- Chapter 33 Sex Addiction.- Chapter 34 Addiction to Food and Eating Disorders.- Chapter 35 Other Behavioral Addictions.- Section 9.
Co-occurring Disorders.- Chapter 36 Mental Health Disorders.- Chapter 37 Medical Comorbidities.- Part 3: Pharmacological Interventions.- Section 10. Pharmacotherapy for Substance Use Disorders.- Chapter 38 Opioid Use Disorder.- Chapter 39 Alcohol Use Disorder.
- Chapter 40 Nonalcohol Sedative-Hypnotics and Anxiolytics.- Chapter 41 Nicotine and Tobacco Use Disorders.- Chapter 42 Stimulant Use Disorder.- Chapter 43 Caffeine Addiction.- Chapter 44 Cannabinoid Use Disorder.- Chapter 45 Hallucinogen Use Disorder.- Chapter 46 Dissociative Substances.- Chapter 47 Inhalant Use Disorder.
- Chapter 48 Anabolic-Androgenic Steroid Use Disorder.- Chapter 49 Pharmacotherapy for Other Substances Use Disorders.- Chapter 50 Challenges and Future Directions.- Chapter 51 Pharmacological Management of Behavioral Addictions.- Part 4: Psychosocial Interventions.- Section 11. Individual Psychotherapy.- Chapter 52 Motivational Enhancement.
- Chapter 53 Cognitive Behavioral Therapy.- Chapter 54 Dialectical Behavioral Therapy.- Chapter 55 Psychodynamic Psychotherapy.- Section 12. Group Therapy and Community Support.- Chapter 56 12-Step Programs.- Chapter 57 Peer Support Groups.- Chapter 58 Family Therapy.
- Chapter 59 Network Therapy.- Chapter 60 Long-term Recovery Models.- Section 14. Emerging Therapeutic Approaches.- Chapter 62 Mindfulness and Alternative Treatments.- Chapter 62 Technology-Assisted Therapies.- Chapter 63 Novel Psychotherapeutic Modalities.- Part 5: Prevention and Public Health.
- Section 15. Prevention Strategies.- Chapter 64 Universal Prevention.- Chapter 65 Selective Prevention.- Section 16. Public Health Policies.- Chapter 66 Substance Use and the Law.- Chapter 67 Harm Reduction.
- Chapter 68 Advocacy and Public Awareness Campaigns.- Part 6: Special Topics and Future Directions.- Chapter 69 Novel Treatment Approaches.- Chapter 70 Global Perspectives on Substance Use.